Diabetes Mellitus, Type 2 (complications) And NotAfshin Parsa

List of bibliographic references

Number of relevant bibliographic references: 2.

Ident.	Authors (with country if any)	Title
000D49	Per-Henrik Groop [Finlande] ; Mark E. Cooper [Australie] ; Vlado Perkovic [Australie] ; Kumar Sharma [États-Unis] ; Guntram Schernthaner [Autriche] ; Masakazu Haneda [Japon] ; Berthold Hocher [Allemagne] ; Maud Gordat [France] ; Jessica Cescutti [France] ; Hans-Juergen Woerle [Allemagne] ; Maximilian Von Eynatten [Allemagne]	Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2D™ trial.
000E78	Ursula Schmidt-Erfurth [Autriche] ; Gabriele E. Lang [Allemagne] ; Frank G. Holz [Allemagne] ; Reinier O. Schlingemann [Pays-Bas] ; Paolo Lanzetta [Italie] ; Pascale Massin [France] ; Ortrud Gerstner [Suisse] ; Abdelkader Si Bouazza [Suisse] ; Haige Shen [République populaire de Chine] ; Aaron Osborne [Suisse] ; Paul Mitchell [Australie]	Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024